Advertisement

EUROPEAN Device Guide / Self-Expanding Stent Grafts

Company Name Product Name Materials Used Introducer Size (F) Guidewire Compatibility (inch) Stent Diameter (mm) Stent Length (mm) Delivery System Length (cm) CE Mark Indications Comments
BD Interventional Covera AV Nitinol, ePTFE-covered stent 8, 9 0.035 6–10 30, 40, 60, 80, 100 80 Indicated for the treatment of stenoses in the upper extremity venous outflow of patients dialyzing with an AV access graft or fistula
BD Interventional Covera Plus Nitinol 8, 9 0.035 6–10 30, 40, 60, 80, 100 80, 120 Indicated for the treatment of stenoses in the upper extremity venous outflow of patients dialyzing with an AV access graft or fistula and for the treatment of atherosclerotic lesions in iliac and femoral arteries with a reference vessel diameter of 4.5–9 mm
BD Interventional Fluency Plus Nitinol/ePTFE 8–10 0.035 5–10, 12, 13.5 20, 30, 40, 50, 60, 80, 100, 120 80, 117 Residual stenosis with impaired perfusion (pressure gradient) after balloon dilatation, especially in stages III and IV according to Fontaine; dissection; detached arteriosclerotic plaque material and luminal obstruction after balloon dilatation; occlusion after thrombolysis or after aspiration and before dilatation; restenosis or reocclusion
Gore & Associates Gore Viabahn Endoprosthesis Nitinol/ePTFE, gold 7–12 0.035 5, 6, 7, 8, 9, 10, 11, 13 25, 50, 100, 150 75, 120 The endovascular grafting of peripheral arteries and improving blood flow in the symptomatic obstruction of peripheral veins
Gore & Associates Gore Viabahn Endoprosthesis With Propaten Bioactive Surface Nitinol/ePTFE, gold 6–12 0.018/0.014 (5–8 mm), 0.035 (5–13 mm) 5, 6, 7, 8, 9, 10, 11, 13 25, 50, 100, 150, 250 75 (0.035-inch system only), 120 The endovascular grafting of peripheral arteries and improving blood flow in the symptomatic obstruction of peripheral veins
Gore & Associates Gore Viabil Biliary Endoprosthesis Nitinol/ePTFE 8.5 (endoscopic), 10 (percutaneous) 0.035 8, 10 40, 60, 80, 100 40 (percutaneous), 200 (endoscopic) Malignant biliary strictures* *Contraindicated for all cardiovascular applications
Gore & Associates Gore Viatorr TIPS Endoprosthesis with Controlled Expansion Nitinol/ePTFE 10 ≤ 0.035 8–10 60, 70, 80, 90, 100 75 Indicated for use in the treatment of portal hypertension and its complications such as variceal bleeding refractory to, or intolerant of, conventional therapies, inaccessible varices, gastropathy, refractory ascites, and/or hepatic hydrothorax TIPS, transjugular intrahepatic portosystemic shunt
Scitech Medical Solaris Nitinol/PTFE 9 0.035 6–9 40, 60, 80 130 In the treatment of in-stent restenosis in the venous outflow of hemodialysis patients dialyzing by either an arteriovenous (AV) fistula or AV graft; in the treatment of stenosis in the venous outflow of hemodialysis patients dialyzing by an AV graft; restenosis or reocclusion (except vessels on the central circulatory system and central nervous system); dissection (except vessels on the central circulatory system and central nervous system); residual stenosis with impaired perfusion (pressure gradient) following balloon dilatation, especially in stages III and IV according to Fontaine (except vessels on the central circulatory system and central nervous system); detached arteriosclerotic plaque material and luminal obstruction following balloon dilatation (except vessels on the central circulatory system and central nervous system); occlusion after thrombolysis or after aspiration and before dilatation (except vessels on the central circulatory system and central nervous system) Precise deployment, high flexibility, minimal shortening, balanced radial strength
Boston Scientific Corporation Wallgraft Endoprosthesis With Unistep Plus Delivery System Superalloy wire/polyethylene terephthalate graft material 9–12 0.035 6–10, 12, 14 20, 30, 50, 70 Indicated for use for treatment of complex iliac artery stenoses (lesions ≥ 3 cm in length or calcified or eccentric lesions < 3 cm in length) and iliac occlusions in vessels 7–12 mm in diameter; the exclusion of atherosclerotic arterial aneurysms and traumatic vessel disruptions in peripheral vessels 5–12 mm in diameter

Advertisement